Thousand Oaks-based Latigo Biotherapeutics appointed Tim Lugo as its chief financial officer Sept. 9 and also added Beth Seidenberg, co-founder of Westlake Village BioPartners, and Jim Tananbaum to its board of directors. Latigo, a biotech company developing non-opioid pain medicines, said in a press release that these appointments will “bring deep expertise and leadership.” “Tim’s Read More →
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
The Landing at Arroyo, a 212-unit multifamily property in Simi Valley, was sold for $95 million on Aug. 29. The sale was announced by Simi Valley-based Institutional Property Advisors, a division of Marcus & Millichap. With the $95 million price tag, each unit sold and was worth $448,113. The property is located between California State Read More →
While California Lutheran University’s finances remain strong, some “hard decisions” are likely coming, John Nunes, the institution’s new interim president, told the Business Times Aug. 29. “We’re looking at some of the numbers and we see that the numbers in some cases are not heading in the direction that we want,” Nunes, who started his Read More →
The California Department of Food and Agriculture has declared an end to Mediterranean and Queensland fruit fly quarantines in Southern California, including parts of east Ventura County. The action comes following the eradication of the two invasive species, the department announced Aug. 6. In Ventura County, the nine-month-old quarantine had encompassed areas around Thousand Oaks, Read More →
Latigo Biotherapeutics, a clinical-stage biotech company based in Thousand Oaks, announced that it has appointed Nima Farzan to be its CEO. Announced July 22, Farzan brings a “strong track record” with more than two decades of leadership experience in the biopharmaceutical industry. Farzan is also Latigo’s first CEO as he replaces Desmond Padhi, operating partner Read More →